Stock Information
Latest News
News Functions
Additional Functions
13 November 2018
STADA Arzneimittel AG
STADA’s EUR300,000,000 1.75% Senior Notes due 2022: announcement of an instruction to grant in rem securities
23 March 2018
STADA Arzneimittel AG
STADA Arzneimittel AG: Executive Board of STADA Arzneimittel AG decides to file application related to change of sub-segment of the stock exchange
8 March 2018
STADA Arzneimittel AG
STADA: Executive Board and Supervisory Board of STADA Arzneimittel AG resolve on a proposal for the appropriation of profits and propose a dividend in the amount of EUR0.11 per share
1 February 2018
STADA Arzneimittel AG
STADA Arzneimittel AG: Supervisory Board of STADA Arzneimittel AG appoints Peter Goldschmidt as new Chairman of the Executive Board as of September 1, 2018
19 December 2017
STADA Arzneimittel AG
STADA Arzneimittel AG: 19 December 2017, 17.15 hours; STADA: domination and profit and loss transfer agreement pursuant to sections 291 et seqq. AktG concluded between STADA Arzneimittel AG and Nidda Healthcare GmbH
27 September 2017
STADA Arzneimittel AG
STADA Arzneimittel AG: Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman